Pfizer reported better-than-expected second-quarter results on Tuesday, powered by strong demand for blood thinner Eliquis ...

News of the unconfirmed deal talks drew major investor pushback on AZ’s side, with the British drugmaker’s stock sliding nearly 9% following the Financial Times report. The company’s London-listed ...

The Arkansas Board of Pharmacy voted last week to suspend enforcement of Act 630—a bill enacted in April 2025 that restricts manufacturers’ ability ...

Pittsfield — In a press release from Berkshire Music School (BMS) released Monday, August 3, the organization announced that ...

Pfizer reported better-than-expected second-quarter results on Tuesday, powered by strong demand for blood thinner Eliquis ...

IIM Kozhikode inducted the second batch of its four-year BMS programme in Kochi. Women made up 59 per cent of the 120-student cohort, underlining the institute’s focus on diversity.

"Odd" is the word that analysts are using to describe a potential Bristol-Myers Squibb tie-up with AstraZeneca. AstraZeneca and Bristol Myers Squibb are reportedly in talks to merge and create one of ...

Bristol Myers Squibb mega-merger: patent cliffs, oncology synergies, and key risks—get the stock takeaways now.

Companies are trying to be nice to Trump. It’s a charm offensive, but there’s nothing to panic about just yet,” a shareholder ...

In fact, the former lost tens of billions of dollars in market value following reports of a potential tie-up between the ...

Dr. Mehmud will continue to serve as Chief Medical Officer of Medicus and Co-Chairman of Antev providing unified scientific, clinical, regulatory and operational leadership as the Company advances the ...

It’s been years since Big Pharma last witnessed a megamerger. In the late 2010s, Takeda bought Shire, AbbVie acquired ...